Various subpopulations of the tumor-infiltrating T cells express the TRM marker CD103, possibly reacting with E-cadherin expressed by cancer cells and residing in the tumor [68,75], and the expression of CD103 correlates with the cytotoxic function of these T cells with the production of IFNγ and granzymes [67,68,76]. The gene discussed is ITGAE; the disease is cancer.